Cargando…
Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance
PURPOSE: Human epidermal growth factor receptor 2 (HER2) is an emerging therapeutic target in colorectal cancer (CRC). Currently, immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) have been used to determine HER2-positive CRCs; however, the clinical utility of next-generation...
Autores principales: | Yeh, Yu-Min, Lee, Chun-Hui, Chen, Shang-Hung, Lee, Chung-Ta, Chen, Yi-Lin, Lin, Bo-Wen, Lin, Shao-Chieh, Chan, Ren-Hao, Lee, Jenq-Chang, Shen, Meng-Ru, Lin, Peng-Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708395/ https://www.ncbi.nlm.nih.gov/pubmed/31692488 http://dx.doi.org/10.2147/CMAR.S213247 |
Ejemplares similares
-
Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020) -
Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer
por: Chan, Ren-Hao, et al.
Publicado: (2021) -
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment
por: Chung, Bing-Syuan, et al.
Publicado: (2022) -
Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival
por: Lee, Chung-Ta, et al.
Publicado: (2017) -
Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Huang, Yi-Hsuan, et al.
Publicado: (2021)